Impairing protein–protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa
Journal of Peptide Science · 2025
DOI: 10.1002/psc.3658 ↗At a glance
Journal article in Journal of Peptide Science, 2025. Written by Michela Bollati and 12 co-authors. Institution: Institute of Biophysics, National Research Council, Milan, Italy. Major MEDLINE topics: Pseudomonas aeruginosa, RNA, Transfer, Anti-Bacterial Agents, Bacterial Proteins. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: Regione Lombardia, Fondazione Regionale per la Ricerca Biomedica of Regione Lombardia, Ministero dell'Università e della Ricerca.
Abstract (original language)
Protein–protein interactions (PPIs) have been recognized as a promising target for the development of new drugs, as proved by the growing number of PPI modulators reaching clinical trials. In this context, peptides represent a valid alternative to small molecules, owing to their unique ability to mimic the target protein structure and interact with wider surface areas. Among the possible fields of interest, bacterial PPIs represent an attractive target to face the urgent necessity to fight antibiotic resistance. Growing attention has been paid to the YgjD/YeaZ/YjeE complex responsible for the essential t 6 A 37 tRNA modification in bacteria. We previously identified an α‐helix on the surface of Pseudomonas aeruginosa YeaZ, crucial for the YeaZ‐YeaZ homodimer formation and the conserved YeaZ‐YgjD interactions. Herein, we present our studies for impairing the PPIs involved in the formation of the YeaZ dimers through synthetic peptide derivatives of this helical moiety, both in vitro with purified components and on P. aeruginosa cells. Our results proved the possibility of targeting those PPIs which are usually essential for protein functioning and thus are refractory to mutational changes and antibiotic resistance development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Biophysics, National Research Council, Milan, Italy.
- Department of Biosciences, Università degli Studi di Milano, Milan, Italy.
- Department of Science and High Technology, Università degli Studi dell'Insubria, Como, Italy.
- Department of Chemistry, Università degli Studi di Milano, Milan, Italy.
- Department of Chemistry, Institute for Biochemistry, University of Cologne, Cologne, Germany.
- Pharmaceutical Science Department, University of Milan, Milan, Italy.
ORCID profiles: Michela Bollati, Paolo Cocomazzi, Sara Pellegrino, Giovanni Bertoni, Silvia Gazzola
Funding
- Regione Lombardia
- Fondazione Regionale per la Ricerca Biomedica of Regione Lombardia
- Ministero dell'Università e della Ricerca
Cite
APA
Bollati, M., Fasola, E., Pieraccini, S., Freddi, F., Cocomazzi, P., Oliva, F., Klußmann, M., Maspero, A., Piarulli, U., Ferrara, S., Pellegrino, S., Bertoni, G., & Gazzola, S. (2025). Impairing protein–protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa. Journal of Peptide Science. https://doi.org/10.1002/psc.3658
Vancouver
Bollati M, Fasola E, Pieraccini S, Freddi F, Cocomazzi P, Oliva F, et al. Impairing protein–protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa. Journal of Peptide Science. 2025. doi:10.1002/psc.3658
BibTeX
@article{Bollati2025,
author = {Bollati, Michela and Fasola, Elettra and Pieraccini, Stefano and Freddi, Francesca and Cocomazzi, Paolo and Oliva, Francesco and Klußmann, Merlin and Maspero, Angelo and Piarulli, Umberto and Ferrara, Silvia and Pellegrino, Sara and Bertoni, Giovanni and Gazzola, Silvia},
title = {Impairing protein–protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa},
journal = {Journal of Peptide Science},
year = {2025},
doi = {10.1002/psc.3658}
}
EUVIMED